IN line with efforts to diversify its business, mainboard-listed Raffles Medical Group has pinned its hopes on the two new hospitals that are under construction in China as the private healthcare...

RAFFLES Medical Group's net profit grew by one per cent to S$16.4 million for the third quarter as lower renewal rates for expatriate plans offset higher local patient loads at the hospitals...

We had initially thought the positive sentiments and low volatility post-Trump election will be temporary but as it appears, a sustained synchronous global recovery is gaining momentum.

WE downgrade the stock to "sell" as: (1) Singapore's growth missed again for the third straight quarter and underlying weakness is structural in our view; (2) management guided for...

SINGAPORE-LISTED Raffles Medical Group achieved a one per cent year-on-year growth in second-quarter revenue to S$120.1 million despite softer-than-expected demand from foreign patients.

MAPLETREE Industrial Trust's (MIT) share price has softened 3.5 per cent since its YTD peak on June 2, versus the FTSE ST Reit Index's 0.6 per cent gain. ...

REFLECTING the tepid state of Singapore's medical tourism, private healthcare provider Raffles Medical Group registered a 1.7 per cent year-on-year dip to S$114.9 million in first-quarter...

RAFFLES Medical Group recorded S$15.5 million net profit in its first quarter, up 0.1 per cent from the same period a year ago, the group said in a Singapore Exchange filing on Monday morning.

Raffles Medical announced that it would develop a new hospital in Chongqing, China, which will have a capacity of 700 beds.

We believe that Mapletree Logistics Trust remains on a growth path.